![Dov Elefant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dov Elefant
Director of Finance/CFO at
FEMASYS INC.
Net worth: 1 131 $ as of 2026-05-30
Profile
Dov S.
Elefant currently works at Femasys, Inc., as Chief Financial Officer from 2022.
Mr. Elefant also formerly worked at Tetragenex Pharmaceuticals, Inc., as Director-Accounting & Finance from 1999 to 2007, Synvista Therapeutics, Inc., as Assistant Controller from 1998 to 1999, Celsus Therapeutics Plc, as Chief Operating & Financial Officer from 2013 to 2015, Althera Medical Ltd., as Chief Financial Officer, Lev Pharmaceuticals, Inc., as Controller from 2007 to 2009, EpiCept Corp., as Controller, VP-Finance & Administration from 1999 to 2007, Cellectar Biosciences, Inc., as Chief Financial Officer & Vice President from 2019 to 2022, and Akari Therapeutics Plc, as Chief Financial Officer from 2012 to 2019.
Mr. Elefant received his undergraduate degree from Sy Syms School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-14 | 2,922 ( 0% ) | 1 131 $ | 2026-05-30 |
Dov Elefant active positions
| Companies | Position | Start |
|---|---|---|
| FEMASYS INC. | Director of Finance/CFO | 2022-02-27 |
Former positions of Dov Elefant
| Companies | Position | End |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Director of Finance/CFO | 2022-02-22 |
| AKARI THERAPEUTICS, PLC | Director of Finance/CFO | 2019-09-14 |
Althera Medical Ltd.
 Althera Medical Ltd. Medical SpecialtiesHealth Technology Develops therapeutic devices for the treatment of various cancers | Director of Finance/CFO | - |
Lev Pharmaceuticals, Inc.
 Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products for the treatment of inflammatory diseases | Comptroller/Controller/Auditor | 2009-01-31 |
EpiCept Corp.
 EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Director of Finance/CFO | 2007-02-28 |
Training of Dov Elefant
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
54
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Synvista Therapeutics, Inc.
 Synvista Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases of cardiovascular aging and diabetes complications | Health Technology |
Celsus Therapeutics Plc
 Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops novel non steroidal anti-inflammatory drugs | Health Technology |
Femasys, Inc.
 Femasys, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a medical device company that focuses on women''s healthcare | Electronic Technology |
Tetragenex Pharmaceuticals, Inc.
 Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and commercializes antibiotics | Health Technology |
Althera Medical Ltd.
Althera Medical Ltd. Medical SpecialtiesHealth Technology Develops therapeutic devices for the treatment of various cancers | Health Technology |
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products for the treatment of inflammatory diseases | Health Technology |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
Sy Syms School of Business
 Sy Syms School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Dov Elefant
